KEYNOTE-811: pembrolizumab in advanced HER2+ gastric cancer
Crossref DOI link: https://doi.org/10.1038/S41575-022-00577-Y
Published Online: 2022-01-11
Published Print: 2022-02
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Hindson, Jordan
Text and Data Mining valid from 2022-01-11
Version of Record valid from 2022-01-11
Article History
First Online: 11 January 2022